UPDATE: Natus Medical (BABY) Tops Q3 EPS by 2c, Beats on Revenues; FY17 EPS/Revenues Guidance Above Consensus

Natus Medical (NASDAQ: BABY) reported Q3 EPS of $0.40, $0.02 better than the analyst estimate of $0.38. Revenue for the quarter came in at $122.6 million versus the consensus estimate of $122.1 million.

• Reports record third quarter 2017 revenue of $122.6 million
• Reports third quarter GAAP earnings (loss) per share of $(0.26) and non-GAAP of $0.40

GUIDANCE:

Natus Medical sees FY2017 EPS of $1.72-$1.76, versus the consensus of $1.70. Natus Medical sees FY2017 revenue of $514.5-516.5 million, versus the consensus of $508.67 million.

Financial Guidance

For the fourth quarter of 2017, the Company provided revenue guidance of $145.0 million to $147.0 million and non-GAAP earnings per share guidance of $0.68 to $0.72.

For the full year 2017, the Company increased revenue guidance of $514.5 million to $516.5 million and increased its non-GAAP earnings per share to $1.72 to $1.76.

For earnings history and earnings-related data on Natus Medical (BABY) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Hydrofarm Holdings Group, Inc. (HYFM) Misses Q2 EPS by 134c
• Silexion Therapeutics (SLXN) Tops Q2 EPS by 793c